Summit Therapeutics Inc. ( SMMT ) on Friday noted that Akeso, Inc. announced the Chinese Health Authorities, the National Medical Products Administration (NMPA) approved ivonescimab for a second indication based on the results of the Phase 3 trial, HARMONi-2 or AK112-303. On Friday, Summit Therapeutics ( SMMT ) stock closed almost 30% lower at around $23.47. HARMONi-2 evaluated monotherapy ivonescimab, PD-1/VEGF...

SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...

01:02 PM EDT, 04/28/2025 (MT Newswires) -- Toyota Motor ( TM ) said Monday it is expanding its commitment to hydrogen technology by introducing heavy-duty hydrogen trucks and investing in hydrogen infrastructure. The company will roll out hydrogen-powered fuel cell electric Class 8 heavy-duty trucks to reduce the number of diesel-powered tractor trailers servicing its North America Parts Center California,...

MEXICO CITY, April 28 (Reuters) - Shares in Mexican cement maker Cemex climbed on Monday as the sale of assets in the Dominican Republic helped its net profit nearly triple in the first three months of 2025, even as the company reported a year-on-year dip in core earnings. Cemex shares climbed 4.5% in morning trading, making it the top gainer...